Ana Galan Cobo

h-index

Research activity per year

Fingerprint

Dive into the research topics where Ana Galan Cobo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

16 Article
1 Comment/debate
1 Review article

Correction to: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (Nature, (2024), 635, 8038, (462-471), 10.1038/s41586-024-07943-7)
Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Cobo, A. G., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., Juan, J. M., Min, C., Yu, Y., Pan, X., Arbour, K. C., Vokes, N., Schmidt, S. T., Molkentine, D., Owen, D. H. & Memmott, R. & 111 others, Patil, P. D., Marmarelis, M. E., Awad, M. M., Murray, J. C., Hellyer, J. A., Gainor, J. F., Dimou, A., Bestvina, C. M., Shu, C. A., Riess, J. W., Blakely, C. M., Pecot, C. V., Mezquita, L., Tabbó, F., Scheffler, M., Digumarthy, S., Mooradian, M. J., Sacher, A. G., Lau, S. C. M., Saltos, A. N., Rotow, J., Johnson, R. P., Liu, C., Stewart, T., Goldberg, S. B., Killam, J., Walther, Z., Schalper, K., Davies, K. D., Woodcock, M. G., Anagnostou, V., Marrone, K. A., Forde, P. M., Ricciuti, B., Venkatraman, D., Van Allen, E. M., Cummings, A. L., Goldman, J. W., Shaish, H., Kier, M., Katz, S., Aggarwal, C., Ni, Y., Azok, J. T., Segal, J., Ritterhouse, L., Neal, J. W., Lacroix, L., Elamin, Y. Y., Negrao, M. V., Le, X., Lam, V. K., Lewis, W. E., Kemp, H. N., Carter, B., Roth, J. A., Swisher, S., Lee, R., Zhou, T., Poteete, A., Kong, Y., Takehara, T., Paula, A. G., Parra Cuentas, E. R., Behrens, C., Wistuba, I. I., Zhang, J., Blumenschein, G. R., Gay, C., Byers, L. A., Gibbons, D. L., Tsao, A., Lee, J. J., Bivona, T. G., Camidge, D. R., Gray, J. E., Leighl, N. B., Levy, B., Brahmer, J. R., Garassino, M. C., Gandara, D. R., Garon, E. B., Rizvi, N. A., Scagliotti, G. V., Wolf, J., Planchard, D., Besse, B., Herbst, R. S., Wakelee, H. A., Pennell, N. A., Shaw, A. T., Jänne, P. A., Carbone, D. P., Hellmann, M. D., Rudin, C. M., Albacker, L., Mann, H., Zhu, Z., Lai, Z., Stewart, R., Peters, S., Johnson, M. L., Wong, K. K., Huang, A., Winslow, M. M., Rosen, M. J., Winters, I. P., Papadimitrakopoulou, V. A., Cascone, T., Jewsbury, P. & Heymach, J. V., Mar 13 2025, In: Nature. 639, 8054, p. E19
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
2 Link opens in a new tab Scopus citations
High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas
Cai, L., Rogers, T. J., Mousavi Jafarabad, R., Vu, H., Yang, C., Novaresi, N., Galán-Cobo, A., Girard, L., Ostrin, E. J., Fahrmann, J. F., Kim, J., Heymach, J. V., O’Donnell, K. A., Xiao, G., Xie, Y., DeBerardinis, R. J. & Minna, J. D., May 2025, In: Cancers. 17, 10, 1681.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Link opens in a new tab Scopus citations
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer
Galan-Cobo, A., Vokes, N. I., Qian, Y., Molkentine, D., Ramkumar, K., Paula, A. G., Pisegna, M., McGrail, D. J., Poteete, A., Cho, S., Do, M. T., Karimi, A., Kong, Y., Solanki, A., Karmokar, A., Floc'h, N., Hughes, A., Sargeant, R., Young, L. & Shen, L. & 19 others, Kar, G., Keshvani, C., Arrechedera, C., Hernandez, S., Schlacher, K., Wang, J., Iyer, S., Conway, J., Keddar, M. R., Milo, M., de Toma, I., Critchlow, S. E., Barrett, J. C., Cosaert, J., Lau, A., Valge-Archer, V., Byers, L. A., Barry, S. T. & Heymach, J. V., Aug 11 2025, In: Cancer cell. 43, 8, p. 1530-1548.e9
Research output: Contribution to journal › Article › peer-review

Open Access
13 Link opens in a new tab Scopus citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Cobo, A. G., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., Juan, J. M., Min, C., Yu, Y., Pan, X., Arbour, K. C., Vokes, N., Schmidt, S. T., Molkentine, D., Owen, D. H. & Memmott, R. & 111 others, Patil, P. D., Marmarelis, M. E., Awad, M. M., Murray, J. C., Hellyer, J. A., Gainor, J. F., Dimou, A., Bestvina, C. M., Shu, C. A., Riess, J. W., Blakely, C. M., Pecot, C. V., Mezquita, L., Tabbó, F., Scheffler, M., Digumarthy, S., Mooradian, M. J., Sacher, A. G., Lau, S. C. M., Saltos, A. N., Rotow, J., Johnson, R. P., Liu, C., Stewart, T., Goldberg, S. B., Killam, J., Walther, Z., Schalper, K., Davies, K. D., Woodcock, M. G., Anagnostou, V., Marrone, K. A., Forde, P. M., Ricciuti, B., Venkatraman, D., Van Allen, E. M., Cummings, A. L., Goldman, J. W., Shaish, H., Kier, M., Katz, S., Aggarwal, C., Ni, Y., Azok, J. T., Segal, J., Ritterhouse, L., Neal, J. W., Lacroix, L., Elamin, Y. Y., Negrao, M. V., Le, X., Lam, V. K., Lewis, W. E., Kemp, H. N., Carter, B., Roth, J. A., Swisher, S., Lee, R., Zhou, T., Poteete, A., Kong, Y., Takehara, T., Paula, A. G., Parra Cuentas, E. R., Behrens, C., Wistuba, I. I., Zhang, J., Blumenschein, G. R., Gay, C., Byers, L. A., Gibbons, D. L., Tsao, A., Lee, J. J., Bivona, T. G., Camidge, D. R., Gray, J. E., Lieghl, N., Levy, B., Brahmer, J. R., Garassino, M. C., Gandara, D. R., Garon, E. B., Rizvi, N. A., Scagliotti, G. V., Wolf, J., Planchard, D., Besse, B., Herbst, R. S., Wakelee, H. A., Pennell, N. A., Shaw, A. T., Jänne, P. A., Carbone, D. P., Hellmann, M. D., Rudin, C. M., Albacker, L., Mann, H., Zhu, Z., Lai, Z., Stewart, R., Peters, S., Johnson, M. L., Wong, K. K., Huang, A., Winslow, M. M., Rosen, M. J., Winters, I. P., Papadimitrakopoulou, V. A., Cascone, T., Jewsbury, P. & Heymach, J. V., Nov 14 2024, In: Nature. 635, 8038, p. 462-471 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
146 Link opens in a new tab Scopus citations
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC
Vokes, N. I., Cobo, A. G., Fernandez-Chas, M., Molkentine, D., Treviño, S., Druker, V., Qian, Y., Patel, S., Schmidt, S., Hong, L., Lewis, J., Rinsurongkawong, W., Rinsurongkawong, V., Lee, J. J., Negrao, M. V., Gibbons, D. L., Vaporciyan, A., Le, X., Wu, J. & Zhang, J. & 4 others, Rigney, U., Iyer, S., Dean, E. & Heymach, J. V., 2023, In: Clinical Cancer Research. 29, 23, p. 4958-4972 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
32 Link opens in a new tab Scopus citations

Ana Galan Cobo

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Correction to: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (Nature, (2024), 635, 8038, (462-471), 10.1038/s41586-024-07943-7)

High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas

KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC

Ana Galan Cobo

Fingerprint

Collaborations and top research areas from the last five years

Research output

Correction to: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (Nature, (2024), 635, 8038, (462-471), 10.1038/s41586-024-07943-7)

High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas

KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC